<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>101(3)</volume><submitter>Vu T</submitter><journal>Haematologica</journal><pagination>e77-80</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4815732</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling.</pubmed_title><pmcid>PMC4815732</pmcid><pubmed_authors>Guignes S</pubmed_authors><pubmed_authors>Lopez AF</pubmed_authors><pubmed_authors>Ramshaw HS</pubmed_authors><pubmed_authors>Lane SW</pubmed_authors><pubmed_authors>Song A</pubmed_authors><pubmed_authors>Austin R</pubmed_authors><pubmed_authors>Vu T</pubmed_authors><pubmed_authors>Kuhn CP</pubmed_authors><pubmed_authors>Hill GR</pubmed_authors><pubmed_authors>Bruedigam C</pubmed_authors><pubmed_authors>Jacquelin S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Jak2V617F driven myeloproliferative neoplasm occurs independently of interleukin-3 receptor beta common signaling.</name><description/><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2025-04-04T08:49:58.541Z</modification><creation>2025-04-04T08:49:58.541Z</creation></dates><accession>S-EPMC4815732</accession><cross_references><pubmed>26589916</pubmed><doi>10.3324/haematol.2015.136705</doi></cross_references></HashMap>